132 related articles for article (PubMed ID: 9893156)
21. The molecular genetic basis for hypertrophic cardiomyopathy.
Marian AJ; Roberts R
J Mol Cell Cardiol; 2001 Apr; 33(4):655-70. PubMed ID: 11273720
[TBL] [Abstract][Full Text] [Related]
22. Expression of proto-oncogenes and gene mutation of sarcomeric proteins in patients with hypertrophic cardiomyopathy.
Kai H; Muraishi A; Sugiu Y; Nishi H; Seki Y; Kuwahara F; Kimura A; Kato H; Imaizumi T
Circ Res; 1998 Sep; 83(6):594-601. PubMed ID: 9742054
[TBL] [Abstract][Full Text] [Related]
23. Autopsy findings in siblings with hypertrophic cardiomyopathy caused by Arg92Trp mutation in the cardiac troponin T gene showing dilated cardiomyopathy-like features.
Shimizu M; Ino H; Yamaguchi M; Terai H; Uchiyama K; Inoue M; Ikeda M; Kawashima A; Mabuchi H
Clin Cardiol; 2003 Nov; 26(11):536-9. PubMed ID: 14640471
[TBL] [Abstract][Full Text] [Related]
24. Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.
Lombardi R; Bell A; Senthil V; Sidhu J; Noseda M; Roberts R; Marian AJ
Cardiovasc Res; 2008 Jul; 79(1):109-17. PubMed ID: 18349139
[TBL] [Abstract][Full Text] [Related]
25. The absence of pathological myofibre disarray in the diabetic heart: is it a paradox?
McLachlan CS; Lasker S; Keramat Ali SM; Wang L; Jelinek H
Acta Cardiol; 2009 Apr; 64(2):267-8. PubMed ID: 19476122
[TBL] [Abstract][Full Text] [Related]
26. Familial hypertrophic cardiomyopathy: a paradigm of the cardiac hypertrophic response to injury.
Marian AJ; Roberts R
Ann Med; 1998 Aug; 30 Suppl 1():24-32. PubMed ID: 9800880
[TBL] [Abstract][Full Text] [Related]
27. Irreversible triggers for hypertrophic cardiomyopathy are established in the early postnatal period.
Cannon L; Yu ZY; Marciniec T; Waardenberg AJ; Iismaa SE; Nikolova-Krstevski V; Neist E; Ohanian M; Qiu MR; Rainer S; Harvey RP; Feneley MP; Graham RM; Fatkin D
J Am Coll Cardiol; 2015 Feb; 65(6):560-9. PubMed ID: 25677315
[TBL] [Abstract][Full Text] [Related]
28. Ca2+ sensitization and potentiation of the maximum level of myofibrillar ATPase activity caused by mutations of troponin T found in familial hypertrophic cardiomyopathy.
Yanaga F; Morimoto S; Ohtsuki I
J Biol Chem; 1999 Mar; 274(13):8806-12. PubMed ID: 10085122
[TBL] [Abstract][Full Text] [Related]
29. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
30. HCM-linked ∆160E cardiac troponin T mutation causes unique progressive structural and molecular ventricular remodeling in transgenic mice.
Moore RK; Grinspan LT; Jimenez J; Guinto PJ; Ertz-Berger B; Tardiff JC
J Mol Cell Cardiol; 2013 May; 58():188-98. PubMed ID: 23434821
[TBL] [Abstract][Full Text] [Related]
31. Ca(2+)-desensitizing effect of a deletion mutation Delta K210 in cardiac troponin T that causes familial dilated cardiomyopathy.
Morimoto S; Lu QW; Harada K; Takahashi-Yanaga F; Minakami R; Ohta M; Sasaguri T; Ohtsuki I
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):913-8. PubMed ID: 11773635
[TBL] [Abstract][Full Text] [Related]
32. Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair.
Schwartz K; Mercadier JJ
J Clin Invest; 2003 Sep; 112(5):652-4. PubMed ID: 12952912
[TBL] [Abstract][Full Text] [Related]
33. Allosteric effects of cardiac troponin TNT1 mutations on actomyosin binding: a novel pathogenic mechanism for hypertrophic cardiomyopathy.
Moore RK; Abdullah S; Tardiff JC
Arch Biochem Biophys; 2014 Jun; 552-553():21-8. PubMed ID: 24480310
[TBL] [Abstract][Full Text] [Related]
34. Deficient cMyBP-C protein expression during cardiomyocyte differentiation underlies human hypertrophic cardiomyopathy cellular phenotypes in disease specific human ES cell derived cardiomyocytes.
Monteiro da Rocha A; Guerrero-Serna G; Helms A; Luzod C; Mironov S; Russell M; Jalife J; Day SM; Smith GD; Herron TJ
J Mol Cell Cardiol; 2016 Oct; 99():197-206. PubMed ID: 27620334
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics and pathogenesis of hypertrophic cardiomyopathy.
Marian AJ; Salek L; Lutucuta S
Minerva Med; 2001 Dec; 92(6):435-51. PubMed ID: 11740432
[TBL] [Abstract][Full Text] [Related]
36. Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia.
Wolf CM; Moskowitz IP; Arno S; Branco DM; Semsarian C; Bernstein SA; Peterson M; Maida M; Morley GE; Fishman G; Berul CI; Seidman CE; Seidman JG
Proc Natl Acad Sci U S A; 2005 Dec; 102(50):18123-8. PubMed ID: 16332958
[TBL] [Abstract][Full Text] [Related]
37. Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice.
Montgomery DE; Tardiff JC; Chandra M
J Physiol; 2001 Oct; 536(Pt 2):583-92. PubMed ID: 11600691
[TBL] [Abstract][Full Text] [Related]
38. Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.
Wijnker PJM; Sequeira V; Kuster DWD; Velden JV
Antioxid Redox Signal; 2019 Aug; 31(4):318-358. PubMed ID: 29490477
[No Abstract] [Full Text] [Related]
39. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
[TBL] [Abstract][Full Text] [Related]
40. Patients with familial hypertrophic cardiomyopathy caused by a Phe110Ile missense mutation in the cardiac troponin T gene have variable cardiac morphologies and a favorable prognosis.
Anan R; Shono H; Kisanuki A; Arima S; Nakao S; Tanaka H
Circulation; 1998 Aug; 98(5):391-7. PubMed ID: 9714088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]